IRIDEX (IRIX)
(Delayed Data from NSDQ)
$1.94 USD
+0.03 (1.57%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $1.94 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IRIX 1.94 +0.03(1.57%)
Will IRIX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IRIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRIX
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
IRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
Lumentum (LITE) Q3 Earnings Beat Estimates
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
Other News for IRIX
Iridex files ot sell 4.95M shares of common stock for holders
IRIDEX files to sell 4.95M shares of common stock for holders
Iridex Frustrates, But Expect A Transaction By Year-End
IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript
IRIDEX GAAP EPS of $0.16 beats by $0.28, revenue of $12.6M misses by $0.2M